Roche is a multinational healthcare and pharmaceutical company based in Basel, Switzerland.
On August 19, 2020, Roche and Regeneron Pharmaceuticals announced a collaboration “on developing and manufacturing REGN-COV2”, Regeneron's experimental monoclonal antibody cocktail for use against COVID-19.1)